These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9827716)

  • 1. Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis.
    Worobec AS; Semere T; Nagata H; Metcalfe DD
    Cancer; 1998 Nov; 83(10):2120-9. PubMed ID: 9827716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.
    Nagata H; Worobec AS; Oh CK; Chowdhury BA; Tannenbaum S; Suzuki Y; Metcalfe DD
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10560-4. PubMed ID: 7479840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.
    Akin C; Kirshenbaum AS; Semere T; Worobec AS; Scott LM; Metcalfe DD
    Exp Hematol; 2000 Feb; 28(2):140-7. PubMed ID: 10706069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-kit mutation in a population of patients with mastocytosis.
    Nagata H; Okada T; Worobec AS; Semere T; Metcalfe DD
    Int Arch Allergy Immunol; 1997; 113(1-3):184-6. PubMed ID: 9130517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis.
    Worobec AS; Akin C; Scott LM; Metcalfe DD
    J Allergy Clin Immunol; 1998 Sep; 102(3):523-4. PubMed ID: 9768597
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.
    Fritsche-Polanz R; Jordan JH; Feix A; Sperr WR; Sunder-Plassmann G; Valent P; Födinger M
    Br J Haematol; 2001 May; 113(2):357-64. PubMed ID: 11380399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.
    Zappulla JP; Dubreuil P; Desbois S; Létard S; Hamouda NB; Daëron M; Delsol G; Arock M; Liblau RS
    J Exp Med; 2005 Dec; 202(12):1635-41. PubMed ID: 16352739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene.
    Yavuz AS; Lipsky PE; Yavuz S; Metcalfe DD; Akin C
    Blood; 2002 Jul; 100(2):661-5. PubMed ID: 12091362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of the proto-oncogene c-kit in patients with mastocytosis.
    Nagata H; Worobec AS; Semere T; Metcalfe DD
    Leukemia; 1998 Feb; 12(2):175-81. PubMed ID: 9519779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.
    Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP
    Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis.
    Chan IJ; Tharp MD
    Clin Exp Dermatol; 2018 Jun; 43(4):416-422. PubMed ID: 29350409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mastocytosis cells bearing a c-kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis.
    Dror Y; Leaker M; Caruana G; Bernstein A; Freedman MH
    Br J Haematol; 2000 Mar; 108(4):729-36. PubMed ID: 10792276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation.
    Yanagihori H; Oyama N; Nakamura K; Kaneko F
    J Mol Diagn; 2005 May; 7(2):252-7. PubMed ID: 15858149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.
    Longley BJ; Metcalfe DD; Tharp M; Wang X; Tyrrell L; Lu SZ; Heitjan D; Ma Y
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1609-14. PubMed ID: 9990072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic and molecular genetic abnormalities in systemic mastocytosis.
    Gupta R; Bain BJ; Knight CL
    Acta Haematol; 2002; 107(2):123-8. PubMed ID: 11919394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis.
    Kristensen T; Vestergaard H; Bindslev-Jensen C; Møller MB; Broesby-Olsen S;
    Am J Hematol; 2014 May; 89(5):493-8. PubMed ID: 24443360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.
    Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J
    J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis.
    Lawley W; Hird H; Mallinder P; McKenna S; Hargadon B; Murray A; Bradding P
    Mutat Res; 2005 May; 572(1-2):1-13. PubMed ID: 15790486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilineage involvement and erythropoietin-"independent" erythroid progenitor cells in a patient with systemic mastocytosis.
    Afonja O; Amorosi E; Ashman L; Takeshita K
    Ann Hematol; 1998 Oct; 77(4):183-6. PubMed ID: 9829852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His.
    Pullarkat VA; Pullarkat ST; Calverley DC; Brynes RK
    Am J Hematol; 2000 Dec; 65(4):307-9. PubMed ID: 11074560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.